Tocilizumab Patterns of Use, Effectiveness, and Safety in Patients with Rheumatoid Arthritis: Final Results from a Set of Multi-National Non-Interventional Studies

Autor: Boulos Haraoui, Gustavo Casado, László Czirják, Andrew Taylor, Lingli Dong, Peter Button, Yves Luder, Roberto Caporali

Publikováno v: Rheumatology and Therapy, Vol 6, Iss 2, Pp 231-243 (2019)

Abstract Introduction The objective of this study was to observe the patterns of usage, efficacy, and safety of tocilizumab (TCZ) in clinical practice in patients with rheumatoid arthritis. Methods Data on the real-world usage, efficacy, and safety o

Externí odkaz: https://doaj.org/article/8be8c41e9d9f4c3a8baca77a65527159

Tocilizumab Patterns of Use, Effectiveness, and Safety in Patients with Rheumatoid Arthritis: Final Results from a Set of Multi-National Non-Interventional Studies

Autor: László Czirják, Andrew L. Taylor, Roberto Caporali, Lingli Dong, Gustavo Casado, Boulos Haraoui, Peter Button, Yves Luder

Publikováno v: Rheumatology and Therapy
Rheumatology and Therapy, Vol 6, Iss 2, Pp 231-243 (2019)

Introduction The objective of this study was to observe the patterns of usage, efficacy, and safety of tocilizumab (TCZ) in clinical practice in patients with rheumatoid arthritis. Methods Data on the real-world usage, efficacy, and safety of TCZ wer

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b349149c619d12b4cdb9b54bd52f4a5
https://doi.org/10.1007/s40744-019-0150-x

Long-term safety and effectiveness of tocilizumab in patients with rheumatoid arthritis and inadequate responses to csDMARDs and/or TNF inhibitors:an open-label study close to clinical practice

Autor: Michael T. Nurmohamed, Jean Sibilia, José Andrés Román Ivorra, Andrew J. K. Östör, Yves Luder, Karel Pavelka, Jenny Devenport, José María Álvaro-Gracia, Paris Sidiropoulos, Vivian P. Bykerk

Publikováno v: Bykerk, V P, Östör, A J K, Alvaro-Gracia, J, Pavelka, K, Román Ivorra, J A, Nurmohamed, M T, Luder, Y, Sidiropoulos, P N M, Devenport, J & Sibilia, J 2019, ' Long-term safety and effectiveness of tocilizumab in patients with rheumatoid arthritis and inadequate responses to csDMARDs and/or TNF inhibitors : an open-label study close to clinical practice ', Clinical Rheumatology, vol. 38, no. 9, pp. 2411-2421 . https://doi.org/10.1007/s10067-019-04535-z
Clinical Rheumatology, 38(9), 2411-2421. Springer London

OBJECTIVE: To assess the long-term safety, tolerability, and effectiveness of tocilizumab (TCZ) as monotherapy or in combination with conventional synthetic disease-modifying antirheumatic drugs (csDMARDs) in clinical practice in patients with modera

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2be02bbc05055baacba31a58c7b83c55
https://research.vumc.nl/en/publications/ae691602-07fc-4a1b-a4e2-b35a473500f7

FRI0262 CLINICAL OUTCOMES OF PATIENTS WITH GIANT CELL ARTERITIS WITH POLYMYALGIA SYMPTOMS ONLY VS CRANIAL SYMPTOMS ONLY TREATED WITH TOCILIZUMAB OR PLACEBO IN THE GIACTA TRIAL

Autor: Jinglan Pei, Robert Spiera, Paris Sidiropoulos, Sebastian Unizony, Yves Luder, Min Bao, John H. Stone

Publikováno v: Poster Presentations.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::57cd8b3c023f1aaba0556af2b42402ac
https://doi.org/10.1136/annrheumdis-2019-eular.1379

Comparative effectiveness of TNF inhibitors and tocilizumab with and without conventional synthetic disease-modifying antirheumatic drugs in a pan-European observational cohort of bio-naïve patients with rheumatoid arthritis

Autor: Denis Mongin, Tore K Kvien, Dan Nordström, Maria José Santos, Delphine S. Courvoisier, Yves Luder, Manuel Pombo-Suarez, Eirik Kristianslund, Ziga Rotar, Catalin Codreanu, Galina Lukina, Florenzo Iannone, Karel Pavelka, Cem Gabay, Markus R. John, Sara Gale, Kim Lauper

Publikováno v: Seminars in Arthritis and Rheumatism (2019)
Lauper, K, Mongin, D, Iannone, F, Kristianslund, E K, Kvien, T K, Nordström, D C, Pavelka, K, Pombo-Suarez, M, Rotar, Z, Santos, M J, Codreanu, C, Lukina, G, Gale, S L, John, M, Luder, Y, Courvoisier, D S & Gabay, C 2019, ' Comparative effectiveness of TNF inhibitors and tocilizumab with and without conventional synthetic disease-modifying antirheumatic drugs in a pan-European observational cohort of bio-naïve patients with rheumatoid arthritis ', Seminars in arthritis and rheumatism . https://doi.org/10.1016/j.semarthrit.2019.06.020

OBJECTIVES: To compare treatment effectiveness in rheumatoid arthritis (RA) patients naïve to biological disease-modifying antirheumatic drugs (bDMARDs) treated with tocilizumab (TCZ) or TNF-inhibitor (TNFi) with (-combo) or without (-mono) conventi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::01f37dc2f6e7908713e58ec90ce00a08
https://archive-ouverte.unige.ch/unige:128225